- Trials with a EudraCT protocol (191)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
191 result(s) found for: Psychosis.
Displaying page 1 of 10.
EudraCT Number: 2007-003035-22 | Sponsor Protocol Number: ACP-103-015 | Start Date*: 2008-11-05 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) SE (Completed) BE (Completed) AT (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003512-12 | Sponsor Protocol Number: ACP-103-041 | Start Date*: 2017-07-21 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: An Open-Label Extension Study to Examine the Safety and Tolerability of Pimavanserin in the Treatment of Parkinson’s Disease Psychosis | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001606-66 | Sponsor Protocol Number: OLZvsLMT-DB | Start Date*: 2005-06-16 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | |||||||||||||
Medical condition: EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000034-42 | Sponsor Protocol Number: 2022-001 | Start Date*: 2022-04-22 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital - Psychiatry, Department of Affective Disorders | ||||||||||||||||||
Full Title: The Estimated 12-Hour Serum Lithium Level Pilot Study | ||||||||||||||||||
Medical condition: Bipolar disorder Unipolar Depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-003051-36 | Sponsor Protocol Number: ACP-103-014 | Start Date*: 2008-09-10 | |||||||||||
Sponsor Name:Acadia Pharmaceuticals Inc | |||||||||||||
Full Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) ES (Completed) SE (Prematurely Ended) BE (Completed) PT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004893-84 | Sponsor Protocol Number: CBD-P | Start Date*: 2019-08-22 | ||||||||||||||||
Sponsor Name:Mental Health Center Glostrup | ||||||||||||||||||
Full Title: Cannabidiol for treatment of non-affective psychosis and cannabis use | ||||||||||||||||||
Medical condition: Non-affective psychosis and lifetime cannabis use | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002906-23 | Sponsor Protocol Number: ACP-103-012 | Start Date*: 2007-11-14 | |||||||||||
Sponsor Name:Acadia Pharmaceuticals Inc | |||||||||||||
Full Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial To Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002608-13 | Sponsor Protocol Number: KCL/KCH-CT2004-1 (26/8/04) | Start Date*: 2005-05-16 |
Sponsor Name:King’s College London & King’s College Hospital | ||
Full Title: Pragmatic Randomised Control Trial of Quetiapine for psychosis in Parkinson’s Disease | ||
Medical condition: Parkinson's Disease with psychosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000465-31 | Sponsor Protocol Number: CannaBiD | Start Date*: 2016-06-29 | |||||||||||||||||||||||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||||||||||||||||||||||
Full Title: Cannabidiol in Bipolar Depression – CannaBiD-Study: An 8-week randomized, double-blind, placebo-controlled clinical trial of Cannabidiol as add-on therapy in bipolar depression | |||||||||||||||||||||||||||||||||
Medical condition: Bipolar disorder, current episode depressed | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022184-35 | Sponsor Protocol Number: ATLAS | Start Date*: 2011-10-04 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: A pragmatic randomised double-blind trial of Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis: The ATLAS Trial | |||||||||||||
Medical condition: late-onset schizophrenia-like psychosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001599-23 | Sponsor Protocol Number: SIMPET-1 | Start Date*: 2016-06-27 | ||||||||||||||||||||||||||
Sponsor Name:University Medical Center Groningen | ||||||||||||||||||||||||||||
Full Title: In Vivo Imaging of Neuroinflammation in Simvastatin-Treated Schizophrenic Patients | ||||||||||||||||||||||||||||
Medical condition: Schizophrenia | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011343-39 | Sponsor Protocol Number: RIS-SCH-4226 | Start Date*: 2009-06-15 | |||||||||||||||||||||||||||||||
Sponsor Name:Janssen-Cilag AB | |||||||||||||||||||||||||||||||||
Full Title: Patient and physician preferences and satisfaction with oral and long-acting injectable long-term antipsychotic treatment for psychotic disorders | |||||||||||||||||||||||||||||||||
Medical condition: Schizophrenia, schizoaffective disorder, delusional disorder, psychotic disorder NOS or any other psychotic disorder patients demanding long term antipsychotic treatment | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: FI (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003972-42 | Sponsor Protocol Number: A1281198 | Start Date*: 2020-08-21 | |||||||||||
Sponsor Name:Pfizer, Inc. | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPO... | |||||||||||||
Medical condition: Bipolar Disorder | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011253-40 | Sponsor Protocol Number: PQ2 | Start Date*: 2009-04-23 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: Paroxetine or Quetiapine in Addition to Mood Stabilizers in Bipolar Depression | |||||||||||||
Medical condition: Major Depressive Episode in Bipolar Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018195-33 | Sponsor Protocol Number: D1443L00079 | Start Date*: 2010-05-11 | |||||||||||
Sponsor Name:Centro de Investigación Biomédica en Red en el Área de Salud Mental (CIBERSAM) | |||||||||||||
Full Title: Eficacia de quetiapina de liberación prolongada vs. placebo como terapia coadyuvante al tratamiento eutimizante en el control de los síntomas subsindrómicos del trastorno bipolar | |||||||||||||
Medical condition: Terapia coadyuvante en el control de los síntomas subsindrómicos del trastorno bipolar | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004746-81 | Sponsor Protocol Number: | Start Date*: 2009-07-20 | ||||||||||||||||
Sponsor Name:Parnassia-BAVO groep [...] | ||||||||||||||||||
Full Title: Effect of amiloride on lithium-induced chronic nephropathy. Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment. | ||||||||||||||||||
Medical condition: Renal failure due to long-term use of lithium salts in patients with bipolar disorders. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004088-26 | Sponsor Protocol Number: A1281201 | Start Date*: 2020-09-03 | |||||||||||
Sponsor Name:Pfizer, Inc. | |||||||||||||
Full Title: 26-WEEK OPEN-LABEL EXTENSION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER (MOST RECENT EPISODE MANIC) | |||||||||||||
Medical condition: Bipolar Disorder | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000370-20 | Sponsor Protocol Number: 2448/2007 | Start Date*: 2008-08-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. | |||||||||||||
Medical condition: bipolar disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004872-31 | Sponsor Protocol Number: SCA102833 | Start Date*: 2016-12-21 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age | |||||||||||||
Medical condition: Bipolar Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003803-31 | Sponsor Protocol Number: PIO-BP | Start Date*: 2015-05-29 | |||||||||||
Sponsor Name:Hospital Universitario Araba (Sede Santiago) | |||||||||||||
Full Title: Adjunct pioglitazone IN THE TREATMENT OF BIPOLAR DISORDER. | |||||||||||||
Medical condition: Bipolar disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
